drugset / Trial / NCT07251153
Pharmacokinetic Comparison of Vonafexor Acid and Its Lysine Salt and Evaluation of Potential Drug-Drug Interactions
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to define and compare the pharmacokinetic (PK) and pharmacodynamic (PD) profile of EYP651 at two dose levels and compare it with Vonafexor Acid PK and PD profile, the Part A. In addition, Part B of the trial will assess the Drug-Drug Interactions (DDI) potential with the high dose of EYP651.
Timeline
- Start
- 2025-10-28
- Primary completion
- 2025-12-18
- Completion
- 2026-10-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | EYP651 | Unknown | — | — |
| Subject | Vonafexor Acid | Unknown | — | — |
Indications
No indication recorded.